Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: Tim McCormick who wrote (17048)	3/14/2000 1:33:00 PM
From: Ilaine	Respond to of 42523

Nature magazine (well-respected British science magazine) has had several editorials decrying Celera's monopoly on gene sequences over the past months. Problem is, both England and US have given Celera patents. How can they take them away? It will be interesting to see how this plays out. If Celera is going to lose its monopoly, there are a lot of other biotech firms that should also be taking it in the 'nads today. I have to say, I don't understand how Celera could get patents on gene sequences which occur in nature, but I am not an expert in this area at all.